Andrew Pogozelski, MD
Advanced Heart Failure and Transplant Cardiology · Pittsburgh, PANPI 1215199898
Payments from drug & device makers
Across 805 payments — averaging $498.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Actelion Pharmaceuticals US, Inc.$167K
- Bayer$84K
- Pfizer$75K
- Merck$41K
- Akcea Therapeutics, Inc.$17K
- United Therapeutics Corporation$14K
- plus $5K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 199 | $166,573 |
| Bayer | 117 | $83,594 |
| Pfizer | 140 | $74,789 |
| Merck | 54 | $40,587 |
| Akcea Therapeutics, Inc. | 27 | $16,759 |
| United Therapeutics Corporation | 27 | $14,125 |
| E.r. Squibb & Sons, L.L.C. | 49 | $685 |
| Edwards Lifesciences | 12 | $608 |
| Novartis | 32 | $506 |
| Amgen | 26 | $483 |
| AstraZeneca | 24 | $450 |
| Johnson & Johnson | 32 | $409 |
| Alnylam Pharmaceuticals Inc. | 11 | $226 |
| Impulse Dynamics (USA) Inc. | 6 | $190 |
| Abbott | 4 | $186 |
| Heartflow, Inc. | 5 | $110 |
| Boehringer Ingelheim | 6 | $108 |
| Gilead | 5 | $67 |
| Kestra Medical Technology Services, Inc. | 2 | $52 |
| Scpharmaceuticals Inc. | 2 | $52 |
| Boston Scientific | 2 | $49 |
| Vifor Pharma, Inc. | 3 | $48 |
| Cardiovascular Systems Inc. | 1 | $46 |
| Liquidia Technologies, Inc. | 2 | $44 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $43 |
| Daiichi Sankyo Inc. | 2 | $40 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Novo Nordisk | 2 | $34 |
| Cvrx, Inc. | 3 | $33 |
| Medtronic | 1 | $32 |
| Chiesi USA, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $20 |
| Bridgebio Pharma, Inc. | 1 | $18 |
| Lantheus Medical Imaging, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
How this compares
$401,062 in reported general payments places this provider in the 85th percentile of 96 advanced heart failure and transplant cardiology providers in Pennsylvania.
See all advanced heart failure and transplant cardiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Pittsburgh
- Amresh RainaPittsburgh$767K
- Ravi RamaniPittsburgh$608K
- Matthew LanderPittsburgh$404K
- Gavin HickeyPittsburgh$390K
- Srinivas MuraliPittsburgh$165K
- Azam HadiPittsburgh$135K
- Mary KeeblerPittsburgh$86K
- Craig AlpertPittsburgh$57K
- Sideris FacarosPittsburgh$21K
- Christopher LinkPittsburgh$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.